Investors Number: 6.0
Funding Status: Early Stage Venture
Headquarters: Vancouver, British Columbia, Canada
Last Funding Date: 2022-01-31
Founded Date: 2021-01-01
Last Funding Type: Series A
Total Funding: 40000000.0
Industry: Early Drug Development